In contrast, GSK 872 treatment significantly blunted infection-induced upregulation of IFN receptor subunits, including the type I IFN receptor subunits Ifnar1 and Ifnar2, and the type II IFN receptor subunits Ifngr1, and Infgr2. The gene discussed is IFNAR1; the disease is infection.